Actionable trade ideas with defined risk and time horizons.
Curated trade ideas across equities, options, and other instruments, featuring clear directional bias, time horizon, and risk considerations. Trade ideas are designed to align market context, technical structure, and risk management principles.
13,816 total articles
<p>NetScout Systems (NTCT) is a steady cash-flow generator in network observability and DDoS/cyber mitigation. The stock trades near $38.84 with a market cap roughly $2.8B, an attractive price-to-free-cash-flow of ~10.9 and EV/EBITDA around 12.2. For investors willing to take a mid-term swing, the risk/reward looks favorable: operational tailwinds …
Assurant's mix of Global Lifestyle and Global Housing businesses is delivering steady top-line growth and strong free cash flow. With a market cap around $14.2B, a P/E near 14, and price sitting above key moving averages, the setup favors a long trade over the next 180 trading days. Entry, stop and target are provided with catalysts and a balanced …
Sandisk (SNDK) is trading at growth-like multiples but is delivering growth and cash flow. With investor-day targets and near-term supply tightness for NAND, I like a directional long into $2,250 with a disciplined stop. This is a trade, not a perpetual buy-and-hold.
OmniAb's discovery platform and a string of co-discovery deals have moved the stock above key moving averages. At a market cap near $564M, the company sits in a sweet spot for partnership-driven rerating. This trade targets a mid-term move into the $4.40 area with a tight stop under recent technical support.
Cisco's upgraded $9B AI order target and strong free cash flow make the stock an attractive buy on pullbacks around $112.42. The trade is a long-term directional idea (46-180 trading days) that leans on continued hyperscaler spending for AI infrastructure. The main caveat: margin pressure from promotional pricing and channel inventory could limit u…
Accenture has been punished sharply in 2026, but its scale, AI partnerships, and record bookings argue for a recovery. This trade buys the pullback with a $170 entry, $220 target and $150 stop, aiming for a long-term re-rating as AI becomes a revenue amplifier rather than a job killer.
ARS Pharma has a new CEO implementing a clear two-pronged program: reduce operating burn and accelerate commercial execution for core products. That combination is rare in small-cap biotech: fewer cash worries and the potential for visible revenue acceleration. This trade idea lays out an entry at $3.25, a stop at $2.50 and a primary target of $6.2…
IBM has fallen roughly one-third from its 52-week high and is trading near $229. The core thesis here is tactical: use a disciplined entry to capture upside from IBM's software-led recovery and steady free cash flow, while protecting against continued mainframe weakness. Valuation is reasonable for a mature tech company (market cap ~$216B, EV ~$270…
Meren Energy offers a double incentive: a high-coupon-style dividend (around 7% today) and a reasonable recovery upside as oil & gas fundamentals normalize. This trade targets an entry at $18.50 with a long-term horizon, a conservative stop under $15.25, and a $26.00 target driven by normalization of multiples and steady free-cash conversion.
Precision BioSciences (DTIL) looks actionable after signals of promising HBV editing data. The stock trades at $7.41 with a market cap of $204.5M and an enterprise value of $140.6M. We lay out a mid-term swing trade sized for event risk: entry $7.41, initial target $12.00, stop loss $5.50. Catalysts include forthcoming clinical readouts and broader…
monday.com's recent workforce reduction is a tactical reset that should materially improve operating leverage, reduce future dilution pressure, and support higher free cash flow. With revenue growth still in the mid-20s, a sub-$90 entry offers a favorable risk-reward into improving margins and improving enterprise traction.
Pfizer offers a compelling mix of yield, cash generation and near-term pipeline excitement (notably berobenatide for weight loss) that supports a tactical long. The stock trades near $27 with a market cap of about $153B, pays a 6.4% yield and generates roughly $11B in free cash flow — metrics that matter for income-minded traders. That said, materi…
Sandisk is trading at $1,787 and is priced for strong growth. Fundamentals and investor-day targets point to continued upside, but NAND memory is cyclical and margins are projected aggressively. This trade idea proposes a tactical long with strict risk controls: entry $1790.00, stop $1630.00, target $2354.39, swing horizon (45 trading days).
HydroGraph Clean Pwr (HGRAF) is trading like a micro-cap breakout candidate: price sits above its key moving averages, momentum indicators are bullish, and short interest has risen to levels that can feed a short squeeze. This trade idea treats the name as a momentum/speculative play tied to the broader graphene/clean-power narrative — entry at $4.…
Swarmer (SWMR) is an early-stage autonomous drone-swarm software company that has real-world deployments and a growing contract pipeline. The stock trades at a steep premium to current revenue, but recent contract projections and bullish technicals create a tactical opportunity to take a small stake while management converts contracts into revenue.…
YPF is outperforming on operations in Vaca Muerta, supported by industrial partnerships and improving technicals. The stock trades near $53 with a market cap of ~$21.8B; macro and political headlines create a tactical buying opportunity. This trade idea outlines an actionable entry, stop, and target for a mid-term swing capturing continued operatio…
Goldman Sachs combines attractive earnings power (EPS $68.79), a reasonable valuation (P/E ~15.3, market cap ~$306B) and direct involvement in large AI infrastructure financing to justify a buy here. This trade idea offers an actionable entry at $1050.00, a stop at $980.00, and a first target of $1150.00 over a position-horizon (45 trading days). T…
Delta Air Lines mixes durable operating margins with an integrated refinery that buffers fuel volatility. At a market cap near $57.6B and an EV/EBITDA of ~6x, the stock offers a favorable risk-reward for a long position targeting $100 over the next 180 trading days, with a tight stop to protect capital.
WhiteHawk Minerals (WHK) is a mineral-and-royalty company focused on U.S. natural gas interests. The stock trades at a $692M market cap, sits near its 10/20-day moving averages, and offers an upcoming $0.11 per-share dividend. Operator-funded development and active leasing/acquisition activity create asymmetric upside with limited capital intensity…
Soluna (SLNH) is a renewable-powered computing play with active expansion in Texas and recent renewable asset acquisitions. The stock trades around $1.33 with a market cap near $325M, negative earnings, and structurally negative free cash flow. This trade idea lays out a disciplined long entry with a mid-term horizon to capture upside from capacity…
Coeur Mining pulled down guidance recently, but the cut looks like short-term conservatism rather than a structural problem. The company trades at a reasonable EV/EBITDA and generates north of $1.15B in free cash flow; combine that with low leverage and a diversified North American asset base and you have a high-conviction swing trade into an overs…
Pagaya's AI underwriting engine is driving higher ABS placement and cash generation, yet the market is re-rating the name after a volatile run. I like a tactical long here: the business is improving, but the multiple should stay constrained until more durable top-line growth and ABS market depth are visible. Entry near $20.94, target $28.00, stop $…
Zoetis traded down more than 50% from its 52-week high as weakness in its Companion Animal portfolio and a series of earnings shocks triggered a selloff and class-action headlines. At roughly $73.25 today, the stock offers a low-teens P/E, solid free cash flow of $2.37B, and a 2.8% dividend yield. This trade recommends a long entry size with a $95 …
Rhythm (RYTM) sits on a commercial, FDA-approved MC4R franchise with growing indications and a promising second agonist in RM-718. With a market cap near $7.95B but implied revenue roughly $240M, Rhythm is priced for durable orphan-market growth. This trade idea lays out a mid-term long with precise entry, stop and target, and a balanced look at ca…
Astera Labs sells high-value connectivity hardware to AI data centers. Strong growth, profitable margins and a near-zero debt balance sheet justify a constructive mid-term trade, but the valuation is rich and customer concentration and execution risk remain. This trade plan targets $380 with a $290 stop over a 45-trading-day swing.
